pharma news today glp-1 obesity drugs today Agonists Weight Loss Market Report, 2025-2030 6 facts about obesity and

The study design was an active-comparator new user design,11 with DPP4 inhibitors as the comparator

A statistically significant improvement in fibrosis was also observed

Here are essential insights to help you make informed decisions: GLP-1 medications like semaglutide are clinically backed tools in weight management, most effective as part of a provider-guided plan

Glucagon is a hormone that helps control blood glucose (sugar)

In the TRIUMPH-1 Phase 3 trial, participants on the highest dose of retatrutide lost an average of 28.3% of their body weight at 80 weeks

Research examined in the 2016 review suggests that these SCFAs can stimulate GLP-1 release by binding to L-cell receptors